Company
Headquarters: Tampa, FL, United States
Employees: 2
CEO: Mr. Thomas J. Wood
$22.9 Million
USD as of Jan. 1, 2024
| Company | Market Cap (USD) |
|---|---|
| Abbott | $192.67 B |
| Stryker Corporation | $113.24 B |
| Medtronic | $111.60 B |
| Boston Scientific Corporation | $85.22 B |
| Shenzhen Mindray Bio-Medical Electronics Co. Ltd | $49.33 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
REMSleep Holdings, Inc. focuses on the development and distribution of products to help people affected by sleep apnea worldwide. It offers DeltaWave CPAP interface device to treat patients with sleep apnea. The company serves home care dealers, private sleep labs, product end users, physicians, medical group, and hospitals, as well as medical associations. REMSleep Holdings, Inc. is headquartered in Tampa, Florida.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
RemSleep Holdings, Inc. has the following listings and related stock indices.
Stock: OTC: RMSL wb_incandescent